Cafepharma Today

June 4 2025 - Moderna will test new COVID shot against placebo, Robert F Kennedy Jr. says
Moderna will test new COVID shot against placebo, Robert F Kennedy Jr. says
Massachusetts’ life sciences job growth flattens after 10+ years of increases
CDC official overseeing COVID-19 vaccine recommendations resigns
Lilly inks deal worth up to $870M to develop long-acting GLP-1 obesity drugs
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

3 Things to Watch With Nektar Therapeutics
Motley Fool
Monday, November 19, 2012 - 1:55pm
tags:
Nektar, Naloxegol, AstraZeneca
Is This Biotech Fishing for a Higher Bid?
Motley Fool
Monday, November 19, 2012 - 1:26pm
tags:
Geron, BioTime, M&A
Picking The Weight Loss Winner In The Arena Vs. Vivus War
Seeking Alpha
Monday, November 19, 2012 - 11:16am
tags:
Arena Pharmaceuticals, Vivus, Belviq, Qsymia
5 Healthcare Companies With Recent Insider Buying
Seeking Alpha
Monday, November 19, 2012 - 11:15am
tags:
Synergy Pharmaceuticals, Progenics, Pacific Biosciences, MAKO, insider trading, Celsion
A Garage Sale for MannKind
Motley Fool
Monday, November 19, 2012 - 11:09am
tags:
MannKind, MKC1106
Alexza receives updated day 180 list of outstanding issues for Adasuve
The Fly on the Wall
Monday, November 19, 2012 - 11:08am
tags:
Alexaza, Adasuve, Europe
Here's 1 Reason Simcere Pharmaceutical Group Looks Weak
Motley Fool
Monday, November 19, 2012 - 11:07am
tags:
Simcere
Amarin announces notification of patent allowance related to Vascepa
Yahoo/Fly on the Wall
Monday, November 19, 2012 - 11:06am
tags:
Vascepa, patents, Amarin
Pfizer says fibromyalgia drug met main goal in late-stage study
Reuters
Monday, November 19, 2012 - 11:05am
tags:
Pfizer, fibromyalgia, pregabalin
Teva, AstraZeneca reportedly competing to court Irish drug company Amarin
Philadelphia Inquirer
Saturday, November 17, 2012 - 2:50pm
tags:
Vascepa, Teva Pharmaceuticals, AstraZeneca, Amarin, M&A
AcelRx phase III study of sublingual Sufentanil NanoTab PCA vs IV PCA morphine for post operative pain meets primary endpoint
Pharmabiz
Saturday, November 17, 2012 - 2:47pm
tags:
AcelRx, Sufentanil NanoTab PCA System, pain management
Raptor cites R&D costs in fiscal 2012 loss
bizjournals
Saturday, November 17, 2012 - 2:43pm
tags:
Raptor Pharmaceuticals, earnings
Here’s Another Hard Knock for GlaxoSmithKline
Wall Street Cheat Street
Saturday, November 17, 2012 - 2:08pm
tags:
GSK, lawsuits
Celldex Releases Data, Biostar Announces Q3 Results Date: Healthcare Business Review
Wall Street Cheat Street
Saturday, November 17, 2012 - 2:07pm
tags:
Celldex, rindopepimut, glioblastoma, Biostar Pharmaceuticals, earnings
No News Equals Bad News for Amarin Investors
Motley Fool
Saturday, November 17, 2012 - 2:05pm
tags:
Amarin
Meningitis vaccine gets nod
Yahoo/Investor's Business Daily
Saturday, November 17, 2012 - 2:04pm
tags:
meningitis, meningitis B, Novartis, vaccines
Abraxane Cancer Trials Help Justify Celgene Buyout
investors.com
Saturday, November 17, 2012 - 2:03pm
tags:
Abraxane, Celgene, pancreatic cancer
Safety Matters (to a Point)
Motley Fool
Saturday, November 17, 2012 - 2:02pm
tags:
Amarin Pushed Closer to Solo Vascepa Launch By Another NCE Delay
The Street
Saturday, November 17, 2012 - 2:01pm
tags:
Amarin, Vascepa, fish oil
Traders Eying Ampio Pharmaceuticals, With 3 Potential Blockbusters In The Red Zone
Seeking Alpha
Saturday, November 17, 2012 - 1:59pm
tags:
Ampio Pharmaceuticals, Ampion, Optina, Zertane, premature ejaculation, diabetic retinopathy, anti-inflammatories

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.